Published in BMJ on October 24, 2014
Lopinavir/Ritonavir Monotherapy as Second-line Antiretroviral Treatment in Resource-Limited Settings: Week 104 Analysis of AIDS Clinical Trials Group (ACTG) A5230. Clin Infect Dis (2015) 1.50
Developing a mHealth intervention to promote uptake of HIV testing among African communities in the conditions: a qualitative study. BMC Public Health (2016) 1.38
Short message service (SMS) reminders and real-time adherence monitoring improve antiretroviral therapy adherence in rural Uganda. AIDS (2016) 1.34
The Meanings in the messages: how SMS reminders and real-time adherence monitoring improve antiretroviral therapy adherence in rural Uganda. AIDS (2016) 1.30
A Framework for Health Communication Across the HIV Treatment Continuum. J Acquir Immune Defic Syndr (2017) 0.96
Theory of planned behavior and adherence in chronic illness: a meta-analysis. J Behav Med (2015) 0.89
Adherence to Antiretroviral Therapy and Virologic Failure: A Meta-Analysis. Medicine (Baltimore) (2016) 0.88
The Acceptability and Perceived Usefulness of a Weekly Clinical SMS Program to Promote HIV Antiretroviral Medication Adherence in KwaZulu-Natal, South Africa. AIDS Behav (2016) 0.83
Feasibility and acceptability of mobile phone short message service as a support for patients receiving antiretroviral therapy in rural Uganda: a cross-sectional study. J Int AIDS Soc (2015) 0.81
Impact of a Daily SMS Medication Reminder System on Tuberculosis Treatment Outcomes: A Randomized Controlled Trial. PLoS One (2016) 0.79
Sizanani: A Randomized Trial of Health System Navigators to Improve Linkage to HIV and TB Care in South Africa. J Acquir Immune Defic Syndr (2016) 0.78
Using mHealth for HIV/TB Treatment Support in Lesotho: Enhancing Patient-Provider Communication in the START Study. J Acquir Immune Defic Syndr (2017) 0.77
Evidence for Technology Interventions to Promote ART Adherence in Adult Populations: a Review of the Literature 2012-2015. Curr HIV/AIDS Rep (2015) 0.76
Protocol for a Randomized Controlled Trial Evaluating Mobile Text Messaging to Promote Retention and Adherence to Antiretroviral Therapy for People Living With HIV in Burkina Faso. JMIR Res Protoc (2016) 0.75
Can HIV reverse transcriptase activity assay be a low-cost alternative for viral load monitoring in resource-limited settings? BMJ Open (2016) 0.75
Mobile phone messaging to improve health. BMJ (2014) 0.75
Factors influencing the efficacy of rilpivirine in HIV-1 subtype C in low- and middle-income countries. J Antimicrob Chemother (2015) 0.75
Improving antiretroviral therapy adherence in resource-limited settings at scale: a discussion of interventions and recommendations. J Int AIDS Soc (2017) 0.75
Acceptability of woman-delivered HIV self-testing to the male partner, and additional interventions: a qualitative study of antenatal care participants in Malawi. J Int AIDS Soc (2017) 0.75
Effects of a mobile phone short message service on antiretroviral treatment adherence in Kenya (WelTel Kenya1): a randomised trial. Lancet (2010) 12.92
Interventions for enhancing medication adherence. Cochrane Database Syst Rev (2008) 11.07
The effectiveness of mobile-health technology-based health behaviour change or disease management interventions for health care consumers: a systematic review. PLoS Med (2013) 9.74
Adherence to HAART: a systematic review of developed and developing nation patient-reported barriers and facilitators. PLoS Med (2006) 8.57
Less than 95% adherence to nonnucleoside reverse-transcriptase inhibitor therapy can lead to viral suppression. Clin Infect Dis (2006) 7.42
The effectiveness of mobile-health technologies to improve health care service delivery processes: a systematic review and meta-analysis. PLoS Med (2013) 5.02
Mobile phone text messaging for promoting adherence to antiretroviral therapy in patients with HIV infection. Cochrane Database Syst Rev (2012) 4.56
Virological follow-up of adult patients in antiretroviral treatment programmes in sub-Saharan Africa: a systematic review. Lancet Infect Dis (2010) 4.41
Scaling up mHealth: where is the evidence? PLoS Med (2013) 4.14
The theory of planned behaviour: reactions and reflections. Psychol Health (2011) 3.73
Efficacy of antiretroviral therapy adherence interventions: a research synthesis of trials, 1996 to 2004. J Acquir Immune Defic Syndr (2006) 3.62
Systematic review of the Hawthorne effect: new concepts are needed to study research participation effects. J Clin Epidemiol (2013) 3.28
Patient support and education for promoting adherence to highly active antiretroviral therapy for HIV/AIDS. Cochrane Database Syst Rev (2006) 2.81
Beyond the intention-to-treat in comparative effectiveness research. Clin Trials (2011) 2.65
Extraordinary heterogeneity of virological outcomes in patients receiving highly antiretroviral therapy and monitored with the World Health Organization public health approach in sub-saharan Africa and southeast Asia. Clin Infect Dis (2013) 2.53
Designing a mobile phone-based intervention to promote adherence to antiretroviral therapy in South India. AIDS Behav (2010) 2.30
Standard care impact on effects of highly active antiretroviral therapy adherence interventions: A meta-analysis of randomized controlled trials. Arch Intern Med (2010) 2.17
Results of a randomized controlled trial to assess the effects of a mobile SMS-based intervention on treatment adherence in HIV/AIDS-infected Brazilian women and impressions and satisfaction with respect to incoming messages. Int J Med Inform (2012) 2.14
HIV-infected patients receiving lopinavir/ritonavir-based antiretroviral therapy achieve high rates of virologic suppression despite adherence rates less than 95%. J Acquir Immune Defic Syndr (2007) 2.13
A review of health behaviour theories: how useful are these for developing interventions to promote long-term medication adherence for TB and HIV/AIDS? BMC Public Health (2007) 2.11
The Cameroon Mobile Phone SMS (CAMPS) trial: a randomized trial of text messaging versus usual care for adherence to antiretroviral therapy. PLoS One (2012) 2.05
Levels of adherence required for virologic suppression among newer antiretroviral medications. Ann Pharmacother (2011) 1.82
The risk of virologic failure decreases with duration of HIV suppression, at greater than 50% adherence to antiretroviral therapy. PLoS One (2009) 1.72
Using daily text-message reminders to improve adherence with oral contraceptives: a randomized controlled trial. Obstet Gynecol (2010) 1.72
Changes over time in risk of initial virological failure of combination antiretroviral therapy: a multicohort analysis, 1996 to 2002. Arch Intern Med (2006) 1.69
Mobile phone text messages for improving adherence to antiretroviral therapy (ART): an individual patient data meta-analysis of randomised trials. BMJ Open (2013) 1.66
Design of a randomized trial to evaluate the influence of mobile phone reminders on adherence to first line antiretroviral treatment in South India--the HIVIND study protocol. BMC Med Res Methodol (2010) 1.63
Supporting adherence to antiretroviral therapy with mobile phone reminders: results from a cohort in South India. PLoS One (2012) 1.48
mHealth for HIV Treatment & Prevention: A Systematic Review of the Literature. Open AIDS J (2013) 1.47
Two-year treatment outcomes of patients enrolled in India's national first-line antiretroviral therapy programme. Natl Med J India (2010) 1.47
In randomization we trust? There are overlooked problems in experimenting with people in behavioral intervention trials. J Clin Epidemiol (2013) 1.45
The problem of antiretroviral adherence: a self-regulatory model for intervention. AIDS Care (2003) 1.43
Suboptimal adherence associated with virological failure and resistance mutations to first-line highly active antiretroviral therapy (HAART) in Bangalore, India. Int Health (2011) 1.37
Factors associated with attrition, mortality, and loss to follow up after antiretroviral therapy initiation: data from an HIV cohort study in India. Glob Health Action (2013) 1.33
Use of short message service (SMS) to improve malaria chemoprophylaxis compliance after returning from a malaria endemic area. Malar J (2009) 1.19
Adherence to antiretroviral therapy in India: a systematic review and meta-analysis. Indian J Community Med (2013) 1.16
Adherence counseling and reminder text messages improve uptake of antiretroviral therapy in a tertiary hospital in Nigeria. Niger J Clin Pract (2013) 1.16
Involving behavioral scientists, health care providers, and HIV-infected patients as collaborators in theory-based HIV prevention and antiretroviral adherence interventions. J Acquir Immune Defic Syndr (2006) 1.16
High rates of adherence and treatment success in a public and public-private HIV clinic in India: potential benefits of standardized national care delivery systems. BMC Health Serv Res (2011) 1.12
Compliance. Psychother Psychosom (1992) 1.09
Risk of virological failure and drug resistance during first and second-line antiretroviral therapy in a 10-year cohort in Senegal: results from the ANRS 1215 cohort. J Acquir Immune Defic Syndr (2013) 1.05
Ask, don't tell - mobile phones to improve HIV care. N Engl J Med (2013) 1.01
Evaluating adherence to highly active antiretroviral therapy with use of pill counts and viral load measurement in the drug resources enhancement against AIDS and malnutrition program in Mozambique. Clin Infect Dis (2008) 1.01
Adherence to antiretroviral therapy. J Assoc Physicians India (2012) 0.92
The applicability of the Theory of Planned Behaviour in predicting adherence to ART among a South African sample. J Health Psychol (2011) 0.86
Beyond decision making: class, community organizations, and the healthwork of people living with HIV/AIDS. Contributions from institutional ethnographic research. Med Anthropol (2008) 0.81
Can HIV reverse transcriptase activity assay be a low-cost alternative for viral load monitoring in resource-limited settings? BMJ Open (2016) 0.75
Prevention of Intrauterine Growth Restriction and Preterm Birth with Presumptive Antibiotic Treatment of Pregnant Women: A Literature Review. Nestle Nutr Inst Workshop Ser (2015) 0.75